| 1 |
33256013 | One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [99mTc]Tc-DB4 and [111In]In-SG4 in Mice Treated with Entresto. | 2020 Nov 26 |
2 |
| 2 |
30871262 | Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair. | 2019 Mar 13 |
4 |
| 3 |
30897789 | Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses. | 2019 Mar 20 |
4 |
| 4 |
30963606 | Comparative evaluation of the new GRPR-antagonist 111 In-SB9 and 111 In-AMBA in prostate cancer models: Implications of in vivo stability. | 2019 Aug |
3 |
| 5 |
29556947 | In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer. | 2018 Dec |
4 |
| 6 |
29664606 | Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin. | 2018 May 16 |
2 |
| 7 |
28636973 | Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors. | 2017 Sep |
4 |
| 8 |
26722377 | In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies. | 2016 |
2 |
| 9 |
26844849 | Improving the In Vivo Profile of Minigastrin Radiotracers: A Comparative Study Involving the Neutral Endopeptidase Inhibitor Phosphoramidon. | 2016 Feb |
2 |
| 10 |
26881775 | CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis. | 2016 |
3 |
| 11 |
26882895 | Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation. | 2016 Dec |
3 |
| 12 |
25457559 | γ-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease. | 2015 Feb |
1 |
| 13 |
25286347 | In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice. | 2014 Nov |
4 |
| 14 |
23963369 | Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-β peptide(1-40) in mouse brain. | 2013 Nov |
1 |
| 15 |
22387410 | Context-dependent toxicity of amyloid-β peptides on mouse cerebellar cells. | 2012 |
1 |
| 16 |
21224067 | Neprilysin-2 is an important β-amyloid degrading enzyme. | 2011 Jan |
3 |
| 17 |
15993898 | Neutral endopeptidase determines the severity of pancreatitis-associated lung injury. | 2005 Sep |
4 |
| 18 |
11447035 | Deletion of neutral endopeptidase exacerbates intestinal inflammation induced by Clostridium difficile toxin A. | 2001 Aug |
1 |
| 19 |
10749671 | Molecular cloning and biochemical characterization of a new mouse testis soluble-zinc-metallopeptidase of the neprilysin family. | 2000 Apr 15 |
1 |
| 20 |
8284261 | Individual variability in Tyr-Gly-Gly formation from enkephalin hydrolysis in mouse plasma. | 1993 Sep-Oct |
1 |
| 21 |
3123978 | Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome. | 1986 |
1 |
| 22 |
3539055 | Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice. | 1986 Oct |
1 |
| 23 |
6433386 | Enkephalinase inhibition antagonizes the increased susceptibility to seizure induced by REM sleep deprivation. | 1984 |
1 |